Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group (Q74377095)
Jump to navigation
Jump to search
scientific article published on 01 March 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group |
scientific article published on 01 March 1998 |
Statements
Heterogeneous expression of E-cadherin and p53 in prostate cancer: clinical implications. BIOMED-II Markers for Prostate Cancer Study Group (English)
Ruijter E
van de Kaa C
Aalders T
Ruiter D
Miller G
Debruyne F